Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 2G273 | IM / LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 1 | uk208aa | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | LN4928 | IM / RL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | 2052022 | PO / MO |
patient received vaccinations. Within 5-8 minutes of administration, patient had an episode of apnea. This episode was prolonged requiring supplemental oxygen. Once patient was breathing, she appeared awake from with poor color, hypotonia and lethargy until she arrived at the emergency department about 15minutes later.
patient was observed overnight in the hospital